Plain-English translation of NCT04372277 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Psoriasis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether adding foam (a combination topical treatment) to patients already taking Taltz (an injection medication) can improve results for people with psoriasis affecting a small to moderate area of skin. The study wants to see if using both treatments together works better than the injection alone. You would continue your regular Taltz injections while also applying the foam to affected areas.
Even when patients respond well to Taltz injections, some still have patches of psoriasis that don't clear completely. Researchers want to know if combining this medication with a targeted topical treatment could help those stubborn patches heal better.
You likely qualify if…
You likely don't qualify if…
You would continue taking your regular Taltz injections while also applying foam to the psoriasis patches on your skin. The study takes place at a single center in New Jersey and involves 25 people total. You would attend visits where the research team checks how your skin is responding to the combination treatment and watches for any side effects.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States
Phase
Post-approval monitoring
Sponsor
Psoriasis Treatment Center of Central New Jersey
Collaborators
Eli Lilly and Company
Enrollment target
~25 participants
Started
April 2020
Primary completion
March 2021
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2020.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jerry Bagel, MD
Psoriasis Treatment Center of Central New Jersey
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.